PMDA drug package insert
プリミーフォート経腸用液6
PMDA Prescription drug · クリニジェン株式会社 · package insert Apr 28, 2026
Key facts
| Brand names | プリミーフォート経腸用液6, プリミーフォート経腸用液8, プリミーフォート経腸用液CF処方せん医薬品かどうか不明（企業未登録） |
|---|---|
| Nonproprietary names | 人乳由来母乳強化剤 |
| Companies | 製造販売元／クリニジェン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 母乳強化剤 |
| Therapeutic category codes | 873279 |
| YJ codes | 3279109S2024, 3279109S3020, 3279109S4027, 3279109S1028 |
| Approval numbers | 30700AMX00276000, 30700AMX00264000, 30700AMX00265000 |
| Package insert edition | 第2版 |
| Package insert date | Apr 28, 2026 |
| PMDA document key | 850372_3279109S1028_1 |
| PMDA company code | 850372 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: